Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma
Gonzalo López(Icahn School of Medicine at Mount Sinai), Sharon J. Diskin(Children's Hospital of Philadelphia), Javed Khan(Kent State University), Moataz Noureddine(Dana-Farber Cancer Institute), Eric Hyson(Children's Hospital of Philadelphia), Apexa Modi(Children's Hospital of Philadelphia), Zalman Vaksman(Children's Hospital of Philadelphia), Jun S. Wei(Center for Cancer Research), Malcolm A. Smith(National Cancer Institute), Komal S. Rathi(Children's Hospital of Philadelphia), Lance M. Farra(Children's Hospital of Philadelphia), Robert C. Seeger(Ottawa Hospital), Miriam Doepner(GlaxoSmithKline (United States)), Shahab Asgharzadeh(Children's Hospital of Los Angeles), Karina L. Conkrite(Department of Embryology), John M. Maris(Children's Hospital of Philadelphia), Daniela S. Gerhard(United States Department of Health and Human Services), Jaime Guidry Auvil(National Cancer Institute)
Cited by 1
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Replicating genotype–phenotype associations
|Nature|2007|1.4k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k